Complexes of amyloid-beta and cystatin C in the human central nervous system.
A role for cystatin C (CysC) in the pathogenesis of Alzheimer's disease (AD) has been suggested by the genetic linkage of a CysC gene (CST3) polymorphism with late-onset AD, the co-localization of CysC with amyloid-beta (Abeta) in AD brains, and binding of CysC to soluble Abeta in vitro and in mouse models of AD. This study investigates the binding between Abeta and CysC in the human central nervous system. While CysC binding to soluble Abeta was observed in AD patients and controls, a SDS-resistant CysC/Abeta complex was detected exclusively in brains of neuropathologically normal controls, but not in AD cases. The association of CysC with Abeta in brain from control individuals and in cerebrospinal fluid reveals an interaction of these two polypeptides in their soluble form. The association between Abeta and CysC prevented Abeta accumulation and fibrillogenesis in experimental systems, arguing that CysC plays a protective role in the pathogenesis of AD in humans and explains why decreases in CysC concentration caused by the CST3 polymorphism or by specific presenilin 2 mutations can lead to the development of the disease. Thus, enhancing CysC expression or modulating CysC binding to Abeta have important disease-modifying effects, suggesting a novel therapeutic intervention for AD.
Mi
Weiqian
W
Nathan S. Kline Institute, Orangeburg, New York, USA.
Jung
Sonia S
SS
Yu
Haung
H
Schmidt
Stephen D
SD
Nixon
Ralph A
RA
Mathews
Paul M
PM
Tagliavini
Fabrizio
F
Levy
Efrat
E
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000473:pathology*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D016022:Case-Control Studies; D002490:Central Nervous System / Q000378:metabolism*; D055316:Cystatin C / Q000378:metabolism*; D005260:Female; D006801:Humans; D047468:Immunoprecipitation / Q000379:methods; D008297:Male; D008875:Middle Aged
D016229:Amyloid beta-Peptides; D055316:Cystatin C